SPOTLIGHT: Levaquin approval expanded

by admin |

SPOTLIGHT ON... Levaquin approval expanded
Johnson & Johnson's short-course antibiotic Levaquin got the FDA's approval as a treatment for stubborn urinary-tract infections and kidney infection. Release

Suggested Articles

Pfizer building
Pharma

Pfizer's Vyndaqel off and running thanks to diagnosis push

Pfizer's diagnosis-focused launch strategy for Vyndaqel and Vyndamax is paying off with the meds reaching thousands of patients already.

by Eric Sagonowsky
Bavencio
Marketing

Pfizer nixes multiple Bavencio tests

Pfizer terminated a slew of trial cohorts testing Bavencio in combination with its own experimental drugs, as well as one monotherapy trial.

by Angus Liu
Jakafi
Pharma

Incyte doubles down on dermatitis push with Jakafi trial win

With its Eli Lilly-partnered Olumiant nearing filing in atopic dermatitis, Incyte's other JAK med Jakafi is also looking for a win in that indication.

by Kyle Blankenship